1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Lantern Pharma Inc.

Lantern Pharma Inc.

LTRN
Lantern Pharma Inc.US flagNASDAQ Capital Market
3.40
USD
-0.34
- -
43.38MMarket Cap

Income Statement (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
2
2
6
13
14
18
22
18
+ Selling, General & Admin
1
1
4
5
6
6
6
6
+ Research & Development
1
1
2
8
9
12
16
12
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-2
-2
-6
-13
-14
-18
-22
-18
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
-2
-1
-1
+ Interest Expense, Net
- -
- -
- -
- -
- -
-1
-1
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
1
1
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
-1
-1
- -
Pretax Income
-2
-2
-6
-12
-14
-16
-21
-17
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-2
-2
-6
-12
-14
-16
-21
-17
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-2
-2
-6
-12
-14
-16
-21
-17
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
-2
-6
-12
-14
-16
-21
-17
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-2
-2
-6
-12
-14
-16
-21
-17
EBIT
-2
-2
-6
-13
-14
-18
-22
-18
EBITDA
-2
-2
-6
-13
-14
-18
-22
-18
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
EBITA
-2
-2
-6
-13
-14
-18
-22
-18
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
6
6
4
11
11
11
11
- -
Basic EPS, GAAP
-0.28
-0.39
-1.37
-1.13
-1.31
-1.47
-1.93
- -
Basic EPS from Cont Ops
-0.28
-0.39
-1.37
-1.13
-1.31
-1.47
-1.93
- -
Diluted Weighted Avg Shares
6
6
4
11
11
11
11
- -
Diluted EPS, GAAP
-0.28
-0.39
-1.37
-1.13
-1.31
-1.47
-1.93
- -
Diluted EPS from Cont Ops
-0.28
-0.39
-1.37
-1.13
-1.31
-1.47
-1.93
- -

Balance Sheet (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
- -
1
20
73
59
43
25
11
+ Cash, Cash Equivalents & STI
- -
1
19
71
55
41
24
10
+ Cash & Cash Equivalents
- -
1
19
52
37
22
8
4
+ ST Investments
- -
- -
- -
19
18
19
17
6
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
2
4
2
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
1
- -
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
1
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
1
- -
- -
- -
- -
Total Assets
- -
1
20
74
59
44
26
11
+ Payables & Accruals
- -
- -
1
2
3
3
4
4
+ Accounts Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
1
2
3
3
4
4
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
1
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
1
- -
1
2
3
3
4
5
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities
1
- -
1
2
3
3
4
5
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
4
8
32
97
96
96
97
100
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
4
8
32
97
96
96
97
100
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-4
-7
-13
-25
-39
-55
-76
-93
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
- -
1
20
72
56
41
21
7
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
1
20
72
56
41
21
7
Total Liabilities & Equity
- -
1
20
74
59
44
26
11
Shares Outstanding
6
6
6
11
11
11
11
11
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
- -
-1
-19
-52
-37
-22
-8
-4
Net Debt to Equity
220.6
-130.61
-97.07
-71.99
-66.39
-53.63
-35.45
-67.69
Tangible Common Equity Ratio
-46.51
65.83
96.75
96.78
95.24
93.72
82.86
59.21
Current Ratio
0.68
2.52
36.64
31.26
20.99
16.18
5.83
2.4
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-2
-2
-6
-12
-14
-16
-21
-17
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
1
1
2
1
1
1
+ Stock-Based Compensation
- -
- -
1
1
1
1
1
1
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
1
- -
- -
- -
+ Chg in Non-Cash Work Cap
- -
- -
-1
1
-1
1
2
1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
-1
-1
1
1
1
+ Inc (Dec) in Accts Payable
- -
- -
- -
2
1
- -
2
- -
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-1
-2
-6
-11
-13
-14
-18
-16
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
26
69
-2
- -
- -
2
+ Increase in Capital Stock
- -
- -
26
69
- -
- -
- -
2
+ Decrease in Capital Stock
- -
- -
- -
- -
-2
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
-20
- -
-1
3
11
+ Dec in LT Investment
- -
- -
- -
- -
4
7
21
26
+ Inc in LT Investment
- -
- -
- -
-20
-4
-8
-17
-15
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
-20
- -
-1
3
11
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
1
3
-3
-6
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
1
3
24
63
-2
- -
- -
1
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-1
1
18
33
-15
-16
-14
-3
EBITDA
-2
-2
-6
-13
-14
-18
-22
-18
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-1
-2
-6
-11
-13
-14
-18
-16
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-2
-6
-11
-13
-14
-18
-16
Free Cash Flow per Basic Share
-0.2
-0.34
-1.32
-0.97
-1.18
-1.32
-1.66
- -
Price/Free Cash Flow
- -
- -
-14.7
-8.23
-5.14
-3.24
-1.93
- -
Cash Flow to Net Income
0.74
0.88
0.96
0.86
0.9
0.9
0.86
0.92
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -